Your browser doesn't support javascript.
loading
Efficacy of endoscopic ultrasound-guided gastroenterostomy using self-expandable metallic stent for afferent loop syndrome: A single-center retrospective study.
Hagiwara, Yuya; Hijioka, Susumu; Nagashio, Yoshikuni; Maruki, Yuta; Ohba, Akihiro; Kawasaki, Yuki; Takeshita, Kotaro; Takasaki, Tetsuro; Agarie, Daiki; Hara, Hidenobu; Yagi, Shin; Fukuda, Soma; Kuwada, Masaru; Yamashige, Daiki; Okamoto, Kohei; Chatto, Mark; Kondo, Shunsuke; Morizane, Chigusa; Ueno, Hideki; Endo, Masato; Sugawara, Shunsuke; Sone, Miyuki; Saito, Yutaka; Tsuchiya, Kiichiro; Okusaka, Takuji.
Affiliation
  • Hagiwara Y; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hijioka S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Nagashio Y; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Maruki Y; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ohba A; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kawasaki Y; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Takeshita K; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Takasaki T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Agarie D; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Hara H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yagi S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Fukuda S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kuwada M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yamashige D; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Okamoto K; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Chatto M; Makati Medical Center, Manila, Philippines.
  • Kondo S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Morizane C; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ueno H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Endo M; Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Sugawara S; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Sone M; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
  • Saito Y; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
  • Tsuchiya K; Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
J Gastroenterol Hepatol ; 39(10): 2136-2142, 2024 Oct.
Article in En | MEDLINE | ID: mdl-38845460
ABSTRACT
BACKGROUND AND

AIM:

Endoscopic ultrasound-guided gastroenterostomy is a procedure used to connect the stomach and dilated afferent loop using a stent under endoscopic ultrasound for afferent loop syndrome. However, the actual efficacy and safety of this procedure remain unclear. Therefore, this retrospective study aimed to evaluate the efficacy and safety of endoscopic ultrasound-guided gastroenterostomy using a laser-cut-type fully covered self-expandable metallic stent and an anchoring plastic stent for afferent loop syndrome.

METHODS:

Technical and clinical success rates, adverse events, recurrent intestinal obstruction rates, time to recurrent intestinal obstruction, and technical and clinical success rates of re-intervention were evaluated in intended patients who underwent endoscopic ultrasound-guided gastroenterostomy for afferent loop syndrome from October 2018 to August 2022.

RESULTS:

In 25 intended patients with afferent loop syndrome who intended endoscopic ultrasound-guided gastroenterostomy, the technical success rate was 100% (25/25), whereas the clinical success rate was 96% (24/25). Two patients experienced grade ≥ 3 early adverse events, including one with intra-abdominal abscess and one with hypotension. Both events were attributed to intestinal fluid leakage. No late adverse events were observed. The recurrent intestinal obstruction rate was 32% (8/25), and the median time to recurrent intestinal obstruction was 6.5 months (95% confidence interval 2.8-not available). The technical and clinical success rates of re-intervention were both 100% (8/8).

CONCLUSIONS:

Endoscopic ultrasound-guided gastroenterostomy using a fully covered self-expandable metallic stent and an anchoring plastic stent is effective and safe as a treatment procedure for afferent loop syndrome.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroenterostomy / Endosonography / Afferent Loop Syndrome / Self Expandable Metallic Stents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroenterostomy / Endosonography / Afferent Loop Syndrome / Self Expandable Metallic Stents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Australia